Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-23-000024

Chief Accounting Officer sold 282 shares at $14.95 ($4,216)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Azoy Alexander · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-01 Sale : show line 1 in the form 10b5-1 −282 $14.95 $4,216 11,596 D
Open-market sales · 282 sh · avg $14.95 · $4,216
Loading xslF345X05/wk-form4_1701811666.xml…